Smokeless tobacco and cardiovascular disease

Progress in Cardiovascular Diseases

Volumn 45, Issue 5, 2003, Pages 383-394

  Asplund, Kjell ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN; NICOTINE; THROMBOXANE A2; VITAMIN;

ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHEMICAL COMPOSITION; DISEASE ASSOCIATION; HEALTH HAZARD; HEART INFARCTION; HEART OUTPUT; HEART RATE; HEMATOCRIT; HEMODYNAMICS; HUMAN; LEUKOCYTE COUNT; PATHOGENESIS; PREVALENCE; PUBLIC HEALTH; REVIEW; SCANDINAVIA; SMOKELESS TOBACCO; UNITED STATES; WORKLOAD;

EID: 0037357131     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2003.00102     Document Type: Review

References (65)

1. Nilsson R: A qualitative and quantitative risk assessment of snuff dipping. Regul Toxicol Pharmacol 28:1-16, 1998
2. Hoffmann D, Djordjevic MV, Fan J, et al: Five leading U.S. commercial brands of moist snuff in 1994: Assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 87:1862-1869, 1995
3. Anonymous: Behavioral Risk Factor Surveillance System. Available: http://apps.nccd.cdc.gov/brfss. National Center for Chronic Disease Prevention and Health Promotion (CDC), 2002
4. Rigotti NA, Lee JE, Wechsler H: US college students' use of tobacco products: Results of a national survey. JAMA 284:699-705, 2000
5. Ernster V, Grady D, Greene J, et al: Smokeless tobacco use and health effects among baseball players. JAMA 264:218-224, 1990
6. Siegel D, Benowitz N, Ernster VL, et al: Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health 82:417-421, 1992
7. Wetter D, McClure J, De Moor C, et al: Concomitant use of cigarettes and smokeless tobacco: Prevalence, correlates, and predictors of tobacco cessation. Prev Med 34:638-648, 2002
8. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355:675-687, 2000
9. Rodu B, Stegmayr B, Nasic S, et al: Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 252:398-404, 2002
10. Lindström M, Isacsson S-O: Smoking cessation among daily smokers, aged 45-69 years: A longitudinal study in Malmö, Sweden. Addiction 97:205-215, 2002
11. Braverman MT, Svendsen T, Lund KE, et al: Tobacco use by early adolescents in Norway. Eur J Public Health 11:218-224, 2001
12. Haddock CK, Weg MV, DeBon M, et al: Evidence that smokeless tobacco is a gateway for smoking initiation in young adult males. Prev Med 32:262-267, 2001
13. Galanti M, Wickholm S, Gilljam H: Between harm and dangers. Oral snuff use, cigarette smoking and problem behaviours in a survey of Swedish male adolescents. Eur J Public Health 11:340-345, 2001
14. Glover ED, Laflin M, Edwards SW: Age of initiation and switching patterns between smokeless tobacco and cigarettes among college students in the United States. Am J Public Health 79:207-208, 1989
15. Huhtasaari F, Asplund K, Lundberg V, et al: Trends in cardiovascular risk factors in the Northern Sweden MONICA Study: Who are the winners? Cardiovasc Risk Factors 3:215-221, 1993
16. Huhtasaari F, Lundberg V, Eliasson M, et al: Smokeless tobacco as a possible risk factor for myocardial infarction. A population-based study in middle-aged men. J Am Coll Cardiol 34:1784-1790, 1999
17. Benowitz N: The role of nicotine in smoking-related cardiovascular disease. Prev Med 26:412-417, 1997
18. Benowitz NL, Goulay SG: Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol 29:1422-1431, 1997
19. Benowitz N: Systemic absorption and effects of nicotine from smokeless tobacco. Adv Dent Res 11:336-340, 1997
20. Westman EC: Does smokeless tobacco cause hypertension? South Med J 88:716-720, 1995
21. Hirsch JM, Hedner J, Wernstedt L, et al: Hemodynamic effects of the use of snuff. Clin Pharmacol Ther 52:394-401, 1992
22. Fant RV, Henningfield JE, Nelson RA, et al: Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control 8:387-392, 1999
23. Eliasson B, Taskinen MR, Smith U: Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 94:878-881, 1996
24. Persson P-G, Carlsson S, Svanström L, et al: Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 248:103-110, 2000
25. Wennmalm A, Benthin G, Granstrom E, et al: Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 83:1698-1704, 1991
26. Kilaru S, Frangos S, Chen A, et al: Nicotine: A review of its role in atherosclerosis. J Am Coll Surg 193:538-546, 2001
27. Neunteufl T, Heher S, Kostner K, et al: Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 39:251-256, 2002
28. Joseph A, Norman S, Ferry L, et al: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335:1792-1798, 1996
29. Bolinder G, Norén A, de Faire U, et al: Smokeless tobacco use and atherosclerosis: An ultrasonographic investigation of carotid intima thickness in healthy middle-aged men. Atherosclerosis 132:95-103, 1997
30. Wallenfeldt K, Hulthe J, Bokemark L, et al: Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year old men. J Intern Med 250:492-501, 2001
31. WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): A major international collaboration. J Clin Epidemiol 41:105-114, 1988
32. Huhtasaari F, Asplund K, Lundberg V, et al: Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes? BMJ 305:1252-1256, 1992
33. Bolinder G, Alfredsson L, Englund A, et al: Smokeless tobacco use and increased cardiovascular mortality. Am J Public Health 84:399-404, 1994
34. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 298:789-794, 1989
35. Eliasson M, Lundblad D, Hägg E: Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med 230:17-22, 1991
36. Eliasson M, Asplund K, Evrin PE, et al: Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 113:41-53, 1995
37. Bolinder G, Norén A, Wahren J, et al: Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 27:427-433, 1997
38. Nordgren P, Ramström L: Moist snuff in Sweden - tradition and evolution. Br J Addict 85:1107-1112, 1990
39. Benowitz NL, Porchet H, Sheiner L, et al: Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 44:23-28, 1988
40. Nair J, Ohshima H, Nair UJ, et al: Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol 26:149-161, 1996
41. Penn A, Snyder CA: 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 93:275-276, 1997
42. Anonymous: National Institutes of Health consensus statement. Health implications of smokeless tobacco use. Biomed Pharmacother 42:93-98, 1988
43. Schildt EB, Eriksson M, Hardell L, et al: Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 77:341-346, 1998
44. Bouquot JE, Meckstroth RL: Oral cancer in a tobacco-chewing US population - no apparent increased incidence or mortality. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:697-706, 1998
45. Lagergren J, Bergström R, Lindgren A, et al: The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340-346, 2000
46. Rodu B, Cole P: Smokeless tobacco use and cancer of the upper respiratory tract. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:511-515, 2002
47. IARC: Tobacco Habits Other Than Smoking; Betel Quid and Areca Nut Chewing; and Some Related Nitrosamines. Lyon: International Agency for Research on Cancer, 1985
48. Thomas S, Kearsley J: Betel quid and oral cancer: A review. Eur J Cancer 29B:251-255, 1993
49. Axéll T: Oral mucosal changes related to smokeless tobacco usage: Research findings in Scandinavia. Oral Oncol 29B:299-302, 1993
50. Tillgren P, Haglund BJ, Ainetdin T, et al: Who is a successful quitter? One-year follow-up of a National Quit and Win Contest in Sweden. Scand J Soc Med 23:193-201, 1995
51. Johnson N: Tobacco use and oral cancer: A global perspective. J Dent Educ 65:328-339, 2001
52. Idris A, Ibrahim S, Vasstrand E, et al: The Swedish snus and the Sudanese toombak: Are they different? Oral Oncol 34:558-566, 1998
53. Peltzer K: Smokeless tobacco use among urban white and black South Africans. Psychol Rep 85:933-934, 1999
54. Simon D, Iglauer A: The acute effect of chewing tobacco and smoking in habitual users. Ann N Y Acad Sci 90:119-132, 1960
55. Bordia A, Purbiya S, Khabya B, et al: A comparative study of common modes of tobacco use on pulse, blood pressure, electrocardiogram and blood coagulability in patients with coronary artery disease. J Assoc Physicians India 25:395-401, 1977
56. Squires WG Jr, Brandon TA, Zinkgraf S, et al: Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med 13:195-206, 1984
57. Clover E, Edwards S, Christen A: Smokeless tobacco research. An interdisciplinary approach. Health Values 8:21-25, 1984
58. Schroeder K, Chen M: Smokeless tobacco and blood pressure (letter). N Engl J Med 312:919, 1985
59. Ksir C, Shank M, Kraemer W, et al: Effects of chewing tobacco on heart rate and blood pressure during exercise. J Sports Med Phys Fitness 26:384-389, 1986
60. Westman E, Guthrie G: Licorice, tobacco chewing and hypertension (letter). N Engl J Med 322:850, 1990
61. Bolinder G, de Faire U: Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens 11:1153-1163, 1998
62. Van Duser B, Raven P: The effects of oral smokeless tobacco on the cardiorespiratory response to exercise. Med Sci Sports Exerc 24:389-395, 1992
63. Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: Blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med 232:327-334, 1992
64. Bolinder G: Long-term use of smokeless tobacco. Cardiovascular mortality and risk factors. Thesis, Karolinska Institute. Stockholm, Sweden, 1997
65. Stegmayr B, Johansson I, Asplund K, et al: Antioxidant vitamin status - effects of smoking, passive smoking and smokeless tobacco. Can J Cardiol 13:312B, 1997 (abstr, suppl B)